Results 221 to 230 of about 18,536,823 (334)

e-7. Experimental Brain Tumor Format on after Transplantation of Glia Cell-line

, 1968
Hideyasu KOMIYA, Atsushi Tominaga, Yuji Kato, T Nakazawa   +3 more
openalex   +2 more sources

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer

Molecular Oncology, EarlyView.
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald, Anna M. Reagan, Charles J. Bailey, Mei Gao, Muqiang Gao, Angelica L. Solomon, Michael J. Cavnar, Prakash K. Pandalai, Mautin T. Barry‐Hundeyin, Megan M. Harper, Justin A. Rueckert, Ángela Turrero, Araceli Tobio, Anxo Vidal, Daniel Roca‐Lema, Elia Álvarez‐Coiradas, Pablo Garrido, Laureano Simón, Joseph Kim   +18 more
wiley   +1 more source

KS-NailMel-1: a novel cell line of nail apparatus melanoma. [PDF]

Hum Cell
Ito T, Tanaka Y, Tanegashima K, Nishio K, Hashimoto H, Ichiki T, Ohno F, Kaku-Ito Y, Nakahara T.   +8 more
europepmc   +1 more source

Re-examination of Growth-promoting Nutrients for L Line Cells in Serum-free Medium

, 1967
Isao Yamane, Hidenori Koyama
openalex   +2 more sources

Cultural Characteristics of a Cell Line Derived from an Equine Sarcoid [PDF]

, 1972
R. E. Watson, John F. England, K. A. Larson   +2 more
openalex   +1 more source

Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias, Ana Oitabén, Sonia Zumalave, Bernardo Rodriguez‐Martin, María Gallardo‐Gómez, Martín Santamarina, Ana Pequeño‐Valtierra, Laura Juaneda‐Magdalena, Ramón García‐Escudero, José Luis López‐Cedrún, Máximo Fraga, José M. C. Tubio, Mónica Martínez‐Fernández   +12 more
wiley   +1 more source

Characterization of a pleomorphic rhabdomyosarcoma cell line. [PDF]

Sci Rep
Stickler S, Lang C, Rieche M, Eggerstorfer MT, Hohenegger M, Hochmair M, Hamilton G.   +6 more
europepmc   +1 more source

BMP antagonist CHRDL2 enhances the cancer stem‐cell phenotype and increases chemotherapy resistance in colorectal cancer

Molecular Oncology, EarlyView.
Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley   +1 more source

The HL-60 clone 15 cell line as a model for leukocyte migration-possibilities and limitations. [PDF]

Front Immunol
Griesbaum L, Weusthof C, Sauer T, Gemoll T, Weirich G, Klimek L, Petry J, Bashiri Dezfouli A, Shoykhet M, Wollenberg B.   +9 more
europepmc   +1 more source

Correlation between nuclear morphology and rate of deoxyribonucleic acid synthesis in a normal cell line. [PDF]

, 1979
Peter G. Dormer, W. Abmayr
openalex   +1 more source